abstract |
The present invention relates to the use of a compound of formula (I), N-oxide, pharmaceutically acceptable addition salt, quaternary amine or stereochemically isomeric form thereof for the manufacture of a medicament for the prevention or treatment of HIV infection:n n n n n n n n Wheren n n A and B each represent a radical of the formulan n n n n n n n -C-D- is the following formulan n n -N = CH = NR 17- (c-1); orn n n -NR 17 -CH = N- (c-2) represents a divalent radical;n n n Provided that when A represents a radical of formula (a), B represents a radical of formula (b),n n n When A represents a radical of formula (b), B represents a radical of formula (a). |